Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.
Carrër
Amélie
A
Poirel
Laurent
L
Pitout
Johann D
JD
Church
Deirdre
D
Nordmann
Patrice
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002170:Canada; D015780:Carbapenems / Q000378:metabolism / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D016868:Serratia Infections / Q000382:microbiology*; D012706:Serratia marcescens / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D015780:Carbapenems; D001618:beta-Lactamases